Emerging Company Showcase
The Immuno-Oncology Investing and Partnering Forum will play host to an Emerging Company Showcase as part of the program agenda. This showcase allows immuno-oncology companies to pitch their drug, device, diagnostic, or software to an audience of investors, CEOs, and executives in the field.
To be eligible to participate, companies must be:
- Addressing an unmet medical need
- Founded no earlier than 2013
- Actively seeking funding (startups that have raised more than $2 million in private capital or that had more than $1M in revenue in 2017 are not eligible for this showcase)
Please note that all companies must have a valid email address and phone number to be eligible for participation in the Emerging Company Showcase. A recent news article or webpage from a investor or parent company may be submitted in lieu of a company website. Selected companies will receive a discounted registration rate of $500 for the Immuno-Oncology Investing and Partnering Forum.